logo

Biotech Daily Dose

Share

arow-nov12.jpg The following are the healthcare stocks that hit a new 52-week high on Monday.

pharma-052317_12nov19.jpg Today's Daily Dose brings you news about the disappointing TreeTopp trial results of ASLAN Pharma; better-than-expected financial results of Castle Biosciences; positive topline results from Kadmon's planned interim analysis of its ROCKstar trial; updated results from NextCure's phase I/II trial with NC318.

pharmaup-nov11.jpg The following are some of today's top gainers in the healthcare sector.

pharma-041017_10nov19.jpg Today's Daily Dose brings you news about Alnylam's new positive efficacy results from its ongoing phase II open-label extension (OLE) study of Lumasiran for the treatment of primary hyperoxaluria type; Five Prime's initial safety data from its phase I clinical trial of FPT155 in patients with advanced solid tumors and Lipocine's much-awaited catalyst.

pharma-040518_07nov19.jpg The following are the healthcare stocks that hit a new 52-week high on Wednesday.

stock-up_06nov19.jpg Shares of Constellation Pharmaceuticals Inc. (CNST) soared as much as 200% in intraday trading, touching an all-time high of $45.42 on Wednesday, as investors were delighted by the preliminary data on CPI-0610 in myelofibrosis published in abstracts by the American Society of Hematology.

graph-nov06.jpg The following are the healthcare stocks that hit a new 52-week high on Tuesday.

investors-nov06.jpg Today's Daily Dose brings you news about the FDA approval of Crescita's enhanced formulation of Pliaglis; failure of Supernus' phase III trial of SPN-810 for the treatment of Impulsive Aggression (IA) in ADHD; NextCure's promising data from phase I portion of its ongoing phase I/II trial of NC318 in advanced or metastatic solid tumors; quarterly financial results of Portola, and KORU Medical.

stephenhahn-nov05.jpg Today's Daily Dose brings you news about AVEO Pharma's regulatory update on its investigational drug Tivozanib in renal cell carcinoma; Halozyme's decision to cut 55% workforce following phase III trial failure; FDA approval of RedHill's drug for Helicobacter pylori; revised protocol of Tonix Pharma's RECOVERY phase III study and the new Commissioner of the FDA.

pharmaup-nov04.jpg The following are some of today's top gainers in the healthcare sector.

arow-nov04.jpg The following are the healthcare stocks that hit a new 52-week high on Friday.

chart-nov01.jpg The following are the healthcare stocks that hit a new 52-week high on Thursday.

pharma-032017_01nov19.jpg Today's Daily Dose brings you news about the reverse split of Applied DNA; the global strategic oncology collaboration between BeiGene and Amgen; better-than-expected earnings reported by Bio-Rad; upcoming catalysts of bluebird bio; licensing agreement between Dicerna Pharma and Roche; and an update on Recro Pharma's intravenous (IV) Meloxicam.

pharmadown-oct31.jpg The following are some of the healthcare stocks that posted the biggest percentage decline on Thursday.

pharmaup-oct31.jpg The following are some of today's top gainers in the healthcare sector.

Follow RTT
>